Literature DB >> 2974889

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

R D Abbott1, R P Donahue, W B Kannel, P W Wilson.   

Abstract

The impact of diabetes on recurrent myocardial infarction (MI) and fatal coronary heart disease was examined in survivors of an initial MI using 34-year follow-up data in the Framingham Study. Among nondiabetic patients, the risk of fatal coronary heart disease was significantly lower in women compared with men (relative risk, 0.6). In the presence of diabetes, however, the risk of recurrent MI in women was twice the risk in men. In addition, the effect of diabetes doubled the risk of recurrent MI in women (relative risk, 2.1) but had an insignificant effect in men. Increased susceptibility to cardiac failure among diabetic women was an important factor in determining survivorship. Women with diabetes developed cardiac failure four times more often (16%) than women without diabetes (3.8%). Furthermore, when cardiac failure developed, 25% of diabetic women experienced a recurrent MI or fatal coronary event, more than doubling the rate when diabetes was absent. We conclude that in the diabetic patient who survives an MI, cardiac failure is a common occurrence, warranting early detection and vigorous management in periods of convalescence and follow-up. In addition, when cardiac failure appears, control of diabetes assumes added importance, particularly in women, where its effect on survivorship is considerable.

Entities:  

Mesh:

Year:  1988        PMID: 2974889

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  86 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

Review 2.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 3.  A clinical prescription for heart health in midlife women.

Authors:  Chrisandra Shufelt; Erika Dutra; Tina Torbati; Tina Ramineni
Journal:  Maturitas       Date:  2018-11-12       Impact factor: 4.342

Review 4.  Imaging of myocardial metabolism.

Authors:  Pilar Herrero; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

5.  Mortality after myocardial infarction in patients with diabetes mellitus.

Authors:  Akhil Kapur; Rodney De Palma
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

6.  [Tackling lipaemia in diabetes mellitus in primary care].

Authors:  C Llor Vilà
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

7.  Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart.

Authors:  T Hayashi; K Sohmiya; A Ukimura; S Endoh; T Mori; H Shimomura; M Okabe; F Terasaki; Y Kitaura
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 8.  Role of cardiac MRI in diabetes.

Authors:  Ravi V Shah; Siddique A Abbasi; Raymond Y Kwong
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

9.  Factors determining case fatality in myocardial infarction "who dies in a heart attack"?

Authors:  G Wannamethee; P H Whincup; A G Shaper; M Walker; P W MacFarlane
Journal:  Br Heart J       Date:  1995-09

Review 10.  Impact of hypoglycemic agents on myocardial ischemic preconditioning.

Authors:  Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Whady Hueb
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.